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Abstract
Background: It is of great importance to identify molecular processes and pathways that are involved in disease
etiology. Although there has been an extensive use of various high-throughput methods for this task, pathogenic
pathways are still not completely understood. Often the set of genes or proteins identified as altered in genome-wide
screens show a poor overlap with canonical disease pathways. These findings are difficult to interpret, yet crucial in
order to improve the understanding of the molecular processes underlying the disease progression. We present a
novel method for identifying groups of connected molecules from a set of differentially expressed genes. These
groups represent functional modules sharing common cellular function and involve signaling and regulatory events.
Specifically, our method makes use of Bayesian statistics to identify groups of co-regulated genes based on the
microarray data, where external information about molecular interactions and connections are used as priors in the
group assignments. Markov chain Monte Carlo sampling is used to search for the most reliable grouping.
Results: Simulation results showed that the method improved the ability of identifying correct groups compared to
traditional clustering, especially for small sample sizes. Applied to a microarray heart failure dataset the method found
one large cluster with several genes important for the structure of the extracellular matrix and a smaller group with
many genes involved in carbohydrate metabolism. The method was also applied to a microarray dataset on
melanoma cancer patients with or without metastasis, where the main cluster was dominated by genes related to
keratinocyte differentiation.
Conclusion: Our method found clusters overlapping with known pathogenic processes, but also pointed to new
connections extending beyond the classical pathways.
Background
High-throughput experimental techniques provide objec-
tive views of the molecular changes that occur in cells
during disease progression. A widely used tool when try-
ing to understand the biological meaning of the observed
changes is pathway analysis. In pathway analysis, the list
of significantly altered genes or molecules is mapped onto
usually pre-compiled pathways. A wide range of methods
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for finding pre-defined pathways overrepresented by sig-
nificant genes have been developed and are steadily used,
e.g. [1-3]. However, this strategy for identifying the impor-
tant disease pathways is limited, as pathways are not fixed
and change with context [4]. As a consequence, many of
the significantly altered genes or molecules fall outside of
the expected pathways [5].
An alternative approach, which is fundamentally dif-
ferent from the pathway analysis just described, is a
purely data-driven approach, in which the experimental
data is used without any guidance from prior knowledge
about molecular interactions. The goal is then to discover
hidden patterns of correlation between genes reflect-
ing the complex processes and pathways that underlie
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cellular metabolism and physiology [6]. The most com-
mon approach for this task is unsupervised clustering.
This class of methods was of the first to be applied to
microarray data [7], and several approaches have been
proposed, e.g hierarchical and k-means clustering, Pre-
diction Around Medoids (PAM) [8], model-based cluster-
ing via Markov chain Monte Carlo (MCMC), e.g [9,10],
tight clustering [11] and clustering via networks [12].
Another way of learning molecular relationships from
microarray data is to use Bayesian network (BN) method-
ology. Instead of finding groups of correlated molecules,
BN methodology infers a network of (direct) interacting
molecules. BNs were first proposed for microarray data in
2000 [13], and have also been much applied.
Along with the development of such unsupervised
methods, there has been a steady development of prior
information about molecular interactions. In addition
to the mentioned pathways, there are many databases
containing pairwise connections, such as protein-protein
interactions, transcription factors binding to genes and
protein sequence similarities. Such information is maybe
a more reliable source of information than pathways,
as the latter lack proper definitions, and are as already
mentioned heavily context dependent.
Bayes’ formula is well suited for taking prior information
into account during inference, and says
p(M|D) = p(D|M)p(M)p(D) ∝ p(D|M)p(M).
The goal of the analysis is the posterior probability
p(M|D), i.e. the probability that the model (M) is correct
given the data (D). In our setting, the model M repre-
sents a clustering or a network configuration, whereas
D represents the microarray data. Many methods using
BN methodology to incorporate informative priors have
been proposed quite recently, e.g [14-17]. However, even
with the help of prior information, inferring Bayesian
networks for large numbers of genes remains computa-
tionally challenging, and the number of genes that can be
included is usually smaller than one hundred. Inference
about groups or clusters of genes is a less daunting task, as
there are fewer group/cluster configurations than network
configurations. For cluster analysis, there has been some,
but not many, suggestions for how to make use of prior
knowledge, e.g [18]. Many Bayesian model-based clus-
tering methods have been proposed, e.g. [9,10,19,20] but
common to all of these is that they use non-informative
priors. Bayesian clustering with truly informative priors
has to our knowledge not previously been proposed.
In the present paper, we develop a novel method for
clustering using Bayesian statistics and informative pri-
ors making use of Markov chain Monte Carlo (MCMC)
sampling. We name our method MCIP (MCMC Cluster-
ing with Informative Priors). In our method, co-regulation
patterns in the microarray data are used together with
prior knowledge to find groups or modules of inter-
acting genes. Specifically, we propose a method which
searches for an optimal partitioning of the genes into
functional modules, where module assignment is based
on both microarray data and prior knowledge. The prior
value for assigning genes to the same module is retrieved
from databases containing gene pairs with a previously
reported interaction or connection. Markov chain Monte
Carlo (MCMC) sampling is used to search for the most
reliable modules. Having found the modules, we gen-
erate subnetworks consisting of the prior pairs within
each module, hypothesizing that these pairs represent
the direct interactions. In the presented work we use
prior information in forms of protein-protein interaction
data, transcription factor binding predictions and protein
sequence similarities. We apply our method to simulated
data as well as two real-world microarray data sets, one in
heart failure and one in melanoma cancer.
Methods
Assume we have a genomic dataset D, e.g. a microarray
dataset, with measurements of n genes. We want to use
D together with prior knowledge about molecular inter-
actions to find the most likely partitioning into groups or
modules of functionally related genes. Now assume that
the n genes represent k different modules, where K is not
known in advance. Let M = {(im, jm, pm),m ∈ {1, . . . , q}}
be the collection of q gene pairs for which prior knowl-
edge exist, where pm = pim,jm is the prior probability that
gene im and gene jm belong to the same module.
Now let g = (g1, . . . , gn) be a representation of
group/module membership for each of the n genes, where
gj ∈ {1, . . . ,K}. We want to find the most likely division g
intomodules given the data as well as the prior knowledge,
or formally, find the g maximizing P(g | D,M). Using
Bayes’ formula, we have
P(g | D,M) = P(D | g)P(g | M)P(D | M) ∝ P(D | g)P(g | M).
Marginal likelihood given grouping
We start by finding the marginal likelihood given the sub-
division into different groups (modules/clusters) and the
prior information, i.e. P(D | g,M). Assume the data in
group k follow a multivariate normal distribution with
covariance matrix k , whose prior is inverse Wishart
f (k ,mk) wherek describes the prior covariance matrix
and mk describes the sharpness of the prior. Assume also
that all prior information about the data is contained inM,
and that genes belonging to different groups are indepen-
dent of each other. Consequently, we can let each group
k have prior covariance matrix k = ρkIk , where Ik is a
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nk × nk identity matrix and nk is the number of genes in
group k. We thus have that
P(D | g) =
K∏
k=1
|k |mk/2nk ((mk + N)/2)
π(N ·nk)/2|k | + XtkX(mk+N)/2k nk (m/2)
,
(1)
where N is the number of rows in D (number of individ-
uals), Xk is the data matrix for genes belonging to group
k and i() is the multivariate gamma function. If the gene
expressions are standardized to have mean values equal
to zero and variances equal to one, it is natural to choose
ρk = 1 and mk = nk + 2, as this yields expected val-
ues of 1 for the variances, i.e. for the diagonal elements.
The expectancy of the inverse Wishart distribution is
defined only for mk > nk + 1, so this is a minimalistic
way of coding for the knowledge that the data has been
standardized.
Probability of grouping given prior information
Next, we want to find P(g | M), i.e. the probability of
grouping g given the prior information M. Assume we
have n genes and K ∈ {1, . . . , n} groups. Let N(n,K)
denote the number of possible subdivisions of n genes into
K groups. A new gene can be inserted into one of the K
existing groups, or as its own, single-membered, group, so
N(n,K) can be defined recursively by
N(n,K) = K · N(n − 1,K) + N(n − 1,K − 1),
where N(K ,K) = 1. Let Nij(n,K) = K · N(n − 2,K) +
N(n − 2,K − 1) = N(n − 1,K) be the number of sub-
divisions of n genes into K groups where i and j are
in the same group. Let N(n) = ∑nK=1 N(n,K) be the
number of subdivisions of n genes in total and Nij(n) =∑n
K=1 Nij(n,K) =
∑n
K=1 N(n − 1,K) = N(n − 1) be the
number of subdivisions of n genes where i and j are in the
same group.
Now letM = {(im, jm, pm),m ∈ {1, . . . , q}} be the set of q
pairs for which prior knowledge exist, where we define pm
as the prior probability of forcing gene im and jm to belong
to the same group. Consider first the situation where we
have no prior knowledge, i.e. M0 = ∅. Let (K , n) denote
that we have K groups of n objects, and let P(K | M0) =
1/n, i.e equal prior probability for the number of groups.
For a particular grouping g = (g1, . . . , gn) that has a total
of Kg groups, let P(g | M0,Kg)) = I(K = Kg)/N(n,Kg),
i.e. equal probability for all groupings for a given number
of groups Kg . This implies that the probability of grouping
g given no prior knowledge is
P(g | M0) = 1n · N(n,Kg) .
We denote this probably measure PM0 and refer to it as
the baseline prior.
We will now specify a probability measure which has
the same structure as the baseline prior, except that i and
j are forced to be in the same group and will thus be han-
dled as a unit. To do this, consider the situation where we
have one pair of genes that belong to the same group with
probability one. The prior knowledge is then defined as
M1,1 = {(i, j), p1 = 1}. We then have in total Nij(n) =
N(n − 1) possible subdivisions and n − 1 possible num-
ber of groups. The number of subdivisions into K groups
is Nij(n,K) = N(n − 1,K). This means that
P(K | M1,1) = 1n − 1 I(K ≤ n − 1),
P(g |M1,1,K)= 1Nij(n,K) I(gi=gj)=
1
N(n − 1,K) I(gi=gj),
where I is the indicator function, so
P(g | M1,1) = 1
(n − 1)N(n − 1,Kg) I(Kg ≤ n−1, gi = gj).
Call this probability measure PM1,1 .
Then consider the situation where we have one pair
of genes that belong to the same group with probability
p1 = 1. We now define the prior knowledge as M1 =
{(i, j), p1(= 1)}. The idea is that PM1 = p1PM1,1 + (1 −
p1)PM0 , that is a mixture between a probability measure
which forces i and j to be in the same group and a prob-
ability measure that treats all genes equally (the baseline
prior). Following this idea, we have
P(g |M1)= p1I(Kg ≤ n − 1, gi = gj)
(n − 1)N(n − 1,Kg) +(1−p1)
1
n · N(n,Kg) .
Now let’s generalize to the situation where we have q
pairs of genes with existing prior knowledge, i.e. we have
M = {(im, jm, pm),m ∈ {1, . . . , q}} with pm = pim ,jm . Since
we have a probability for each pair, we need to introduce
some notation specifying what pairs in the prior that are
forced to be in the same group. This can be achieved by
introducing X = {Xm},m ∈ 1, . . . , q, where Xm ∈ {0, 1}
indicates whether the pair (im, jm) is forced to be in the
same group or not, and MX = {(im, jm, pm)|Xm = 1} are
the pairs that are forced together. We also define the total
number of forced pairs for such a combination Xas x =∑q
m=1 Xm. We have that
P(K , | Mx) = 1n − xI(K ≤ n − x),
P(g | MX ,K) = I(Kg < n − x, gim = gjm∀m | Xm = 1)N(n − x,Kg) ,
and thus
P(g | MX) = I(Kg < n − x, gim = gjm∀m | Xm = 1)
(n − x)N(n − x,Kg) .
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Since we have
P(MX) =
q∏
m=1
pXmm (1 − pm)1−Xm ,
and P(g | M) =∑X P(g | MX)P(MX), we arrive at
P(g | M) =
∑
X
( q∏
m=1
pXmm (1 − pm)1−Xm
)
× I(Kg ≤ n − x, gim = gjm∀m | Xm = 1)
(n − x)N(n − x,Kg) .
(2)
Note that this expression increases exponentially with the
number of prior pairs q. In order to avoid computational
cost increasing exponentially with the number of prior
pairs, we developed aMonte Carlo estimation of P(g | M),
described in Additional file 1.
For a given grouping, the baseline prior contributes to
the overall probability of a grouping with an additive fac-
tor (1− p1)(1− p2) · · · (1− pq)P(g|M0) (see Eq. 2 and the
expression for the baseline prior P(g|M0)). This implies
that the baseline prior will contribute to the probability
of two genes being clustered. Define Pb as the proba-
bility for two genes being in the same group given the
baseline prior M0. It is important that this probability
is non-zero, in order to allow for the possibility of two
arbitrary genes being in the same group whether they
are in the set of prior pairs or not. If not, it would be
impossible to group gene pairs that are not in the set of
specified prior pairs. However, this implies that the prob-
ability of grouping two genes (im , jm) in a prior pair
will be be the mixture pm + (1 − pm)Pb, as there is a
non-zero probability that the genes are connected, even
if they should not be connected according to the prior
information. For instance, if the baseline prior for two
arbitrary genes to be connected is 0.1 and pair number
m has prior enforcement probability pm = 0.8, the total
prior probability for the pair (im, jm) to be connected will
be 0.82.
There will be a baseline probability for two arbitrary
genes to be connected. We have become aware that with
equal probability for all number of groups and equal prob-
ability for each grouping given the number of groups,
the baseline for any two genes to be connected will be
dependent on the total number of genes, n. In general,
we get that the prior for groupings gives that the base-
line probability, Pb for two genes to be connected when
there are K groups will be P(i and j in the same group
| K groups)=N(n − 1,K)/N(n,K). The total probabil-
ity will then be Pb = (1/n)∑K N(n − 1,K)/N(n,K),
which depends on the number of genes in total, n. For
n = 100, Pb = 0.048 while for the extreme case n = 10,
Pb = 0.25. It might be seen as a weakness that there is
any dependency on the number of genes in the dataset
on the baseline probability. An alternative approach could
be to specify the baseline prior according to a given base-
line probability for any arbitrary pair of genes. This would
make for a more consistent baseline prior, but has the dis-
advantage that the baseline prior has to be set manually.
An alternative would be to make the baseline prior into
a parameter to be estimated in a hierarchical Bayesian
model.
Removing cycles
The set of priors might contain cycles, which can easily
occur, e.g if both direct and indirect connections are
included. We have developed an algorithm for detect-
ing cycles, and if such are found, the prior pair with the
smallest prior probability (smallest extra connection prob-
ability) is removed, as this connection is interpreted as
a result of the rest of the cycle. The reason for exclud-
ing cycles in the prior is that with cycles, the pairwise
specification of prior probabilities of pairs could be mis-
leading. As an example, let us assume the prior is spec-
ified so that there is a 0.8 prior probability of a pairing
between gene A and B (prior pair 1), between B and
C (prior pair 2) and between A and C (prior pair 3).
Then the probability for a forced connection between
A and B (thus disregarding the baseline probability) will
be P(A and B forced to be in the same group)=P(prior
pair 1 enforced)+P(prior pair 1 not enforced)P(prior pair
2 enforced)P(prior pair 3 enforced)= 0.8+ 0.2*(0.8*0.8)
= 0.928. Thus in order for the pairwise prior prob-
abilities to be interpreted as the probability for two
pairs to be forced to be connected, cycles should be
avoided.
Markov chain Monte Carlo procedure for integrative
networks
We use Markov chain Monte Carlo (MCMC) to sam-
ple from the posterior distribution P(D | g,M), as the
analytical solution is not known.Wewill use theMetropo-
lis Hastings algorithm, which is the most general ver-
sion of MCMC. Specifically, we propose the following
algorithm:
• Start with a random grouping, called g.
• Sample N groupings g based on the following scheme:
– Propose either (each with probability 1/3)
∗ A partitioning of one of the groups
(except when K = n)
∗ A merging of two of the groups
(except when K = 1)
∗ A transition of one of the genes to
another group (except when K = 1)
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– Call the new grouping gnew.
– Accept gnew with the following probability:
P(accept gnew)=min
(
1, P(D |gnew)P(gnew | M)Q(gold |gnew)P(D |gold)P(gold |M)Q(gnew |gold)
)
,
where P(D | g) is given by (1), P(g | M) is
given by (2) and Q(gx|gy) is the probability of
proposing the group configuration gx from
the configuration gy, and is given by (3-5) in
the next section.
In order to avoid convergence to local maxima, we
implemented parallel tempering [21], as described in
Additional file 1.
Inferring clusters fromMCMC samples
The aboveMCMC procedure results in a series of samples
g. These samples can be used to calculate the posterior
similarity matrix (PSM), in which each entry (i, j) gives the
proportion pij of samples gene i and gene j occur together
in the same cluster. We infer clusters from the PSM using
the minbinder function in the mcclust R library [22].
Specifically, minbinder makes use of hierarchical cluster-
ing with the PSM as distance matrix together with the
cuttree function to produce cluster configurations with
the number of clusters ranging from 1 to L, where L is a
user-specified maximum. Now letting IK (i, j) be the indi-
cator for whether gene i and j are in the same cluster for
the configuration using K clusters (based on hierarchical
clustering and the cuttree function), and using absolute
difference as loss function, the posterior expected loss
eK for K clusters is calculated in minbinder as eK =∑
i<j |IK (i, j) − pij|. The inferred cluster configuration is
the result of hierarchical clustering and cuttree for Kˆ clus-
ters, where Kˆ is the k minimizing the posterior expected
loss, i.e. Kˆ = minK eK .
Proposal distribution
Let n, as before, be the total number of genes, and let nk
be the number of genes in group k and ns be the num-
ber of single-membered groups. If the number of groups
K equals 1, the only allowed option is splitting into two
new groups. If K = n, we can only have a merging of two
genes into a new group. If 1 < K < n, all three types
of moves are allowed (splitting and merging groups, and
moving a gene into another group). Each type of move
then has probability 1/3.
First, consider the situation where g → g′ is due to a
splitting of group k. For the configuration g, we then either
have 1 < K < n, and a splitting is occurring with probabil-
ity 1/3, or K = 1, and this type of move is occurring with
probability 1. The probability of getting the new grouping
g′ is then the product of the probability of having a split
within group k, which is nk/(n−ns), the probability of the
actual splitting of j into two specific new subgroups, which
is 1/N(nk , 2), and the probability of having a split (rather
than a merge or a transition of one of the genes), which is
1/3 · I(1 < K < n) + I(K = 1). That is, we have,
Q(g | g′) = nkn − ns ·
1
N(nk , 2)
(0 · I(K = n)
+ 13 I(1 < K < n) + I(K = 1)).
(3)
Next, consider the situation where g → g′ is due to a
merging of group k and l. A merging happens with prob-
ability one if the number of groups is equal to n and with
probability 1/3 if 1 < k < n. Two groups, l and k, are
chosen by first sampling a random gene and finding which
group the gene belongs to, then picking another random
gene and re-sampling as long as that other gene belongs
to the same group. The probability of merging group l
and group j has thus a proposal probability P(merge l
and j)= P(choose l and k | merge)P(merge)= [P(choose
k first)P(choose l second | k chosen first)+P(choose l
first)P(choose k second | l chosen first)] P(merge). That is,
we have
Q(g | g′) =
(nk
n ·
nl
n − nk +
nl
n ·
nk
n − nl
)
×
(
I(K = 1) + 13 I(1 < K < n)
) (4)
Finally, consider the situation where g → g′ is the
result of moving a gene in group l to group k. A move of
one gene from group l to group k is proposed by sam-
pling a random gene and re-sampling if the gene itself
constitutes a single-membered group. Another random
gene not belonging to group l is then sampled, defining
another group k. A random element from group l is then
assigned group identity k. The proposal probability thus
becomes P(move the kth gene of group l to group k)=
P(choose group l to move from and group k to move
to and choose ith element of group l | move)P(move)=
P(choose group l)P(choose group k | group l)P(choose ith
element from group l)P(move)= (nl/(n − ns))(nk/(n −
nl))(1/nl)(1/3)I(1 < K < n). Thus, we have
Q(g | g′) = nk
(n − ns)(n − nl)
1
3 I(0 < K < n). (5)
Computational aspects
The likelihood estimation involves the determinant func-
tion, which isO(n3) in the number n of genes in eachmod-
ule. In our method, the most computationally expensive
calculation is the exact calculation of the prior probabil-
ity P(g|M). This calculation is exponential in the number
of prior pairs. Often, as is the case for the data used in
this paper, the number of pairs for which there exist prior
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knowledge, can be substantial. To deal with such situa-
tions, we developed an approximate estimate of the prior
probability based on Monte Carlo simulations. Compar-
isons on moderately large number of priors suggested that
although less accurate, aMonte Carlo estimate of the prior
gives results close to the results obtained when calculating
the prior exactly (Additional file 2). For larger number of
priors, this can not be tested, but experience shows stable
results, suggesting that the stochastic nature of the algo-
rithm do not seriously affect the results. With 100 genes
and 100 samples and 200 priors, and using 800 for the
Monte Carlo prior calculation, it took our method approx-
imately 10 minutes to run 10000 samples on an 64 GB
RAM, 16 physical CPU cores compute node.
Prior information
We will use three sources of prior information: protein-
protein interactions, transcription factor binding predic-
tions as well as protein sequence similarity calculations.
Gene pairs in these databases have evidence of being
functionally related. The strength of the evidence is rep-
resented by some type of score for each database. In our
MCMC algorithm the prior information is formulated in
terms of the prior probability of forcing two genes to
belong to the same group. We will use the logit transfor-
mation to transform the scores into the unit interval, thus
enabling them to be used as a probabilitymeasure. Further
details are given below for each prior type. There is very
little overlap between the prior information databases.
In cases where a gene pair is found in more than one
database, the highest prior probability will be used.
Protein interaction data
Protein-protein interactions (PPI) are important for the
majority of biological functions. PPI databases contain
lists of proteins pairs for which there exist some evi-
dence for interaction. The evidence comes from various
types of studies, ranging from high-throughput methods,
more traditional low-throughput proteomics studies, as
well as in silico predictions based on known interactions
[23]. iRefIndex [23] is a consolidated protein interaction
database comprising information from nine well-known
interaction databases. One of the features of the database
is the so-called lpr (lowest PMID re-use) score, which is
the lowest number of unique interactions that are sup-
ported by one of the interaction’s PubMed identifiers
(PMID). A low lpr indicates that the interaction is more
likely to rely on low-throughput methods than on high-
throughput methods. As the former is recognized as more
reliable than the latter, the lpr score can be used as a
measure of the reliability of the interaction. We will use
a logit transformation taking x to 1/(1 + exp(−x)) of
the inverse of the lpr score to obtain a probability mea-
sure (between zero and one). For example, if the lpr score
is one, pm becomes 0.73, if the lpr score is zero, pm
becomes 0.5.
Transcription factor bindings
Transcription factors (TF) are proteins that bind to spe-
cific DNA sequences, thereby controlling the expression
levels of the corresponding genes. Binding preferences of
many transcription factors are known and characterized
by a sequence binding motif. However, binding affinity
does not depend entirely on the match of the sequence
to the motif, but will rely also on sequence specific fea-
tures. Ernst et al. [24] developed TF binding predictions,
where they first found a general binding preference of the
sequences based on 28 local genomic features, including
histonemodifications, conservation andmelting tempera-
ture. Then, they combined this general binding preference
score with motif information for specific transcription
factors to improve prediction of genes bound by the fac-
tor. We will make use of these scores, and again, we will
apply the logit transformation to transform the scores to
values between 0 and 1.
Protein sequence similarity
Proteins with similar sequences are likely to be function-
ally related as the proteinsmay be expressed by paralogous
genes (having common ancestry) or by genes that are
selected to have the same function. For instance, two
homologous proteins can be phosphorylated by the same
kinase, thus playing roles in the same signaling pathway.
One additional feature of using protein homology data in
this setting is that the function of proteins for which the
function is unknown can be learned by borrowing infor-
mation from their protein homologs. We will calculate
percent similarity between each of the human proteins in
RefSeq using BLAST [25].
Results
Simulated data
To evaluate the performance of our method we used sim-
ulated gene expression data generated according to [26].
In our study, we used a total of five clusters of genes
C∗ = (C1, . . . ,C5) with dimension N (denoted d in [26])
samples. Cluster sizes nc(c = 1, . . . , 5) were generated
from nc ∼ 2 × Poisson(λ). Expression values in cluster Cc
were generated using a hierarchical log-normal model as
in [26]:
(1) A vector of cluster template for cluster Cc was
created with four periods of constant expression of
sizem1,m2,m3 andm4. The sizes mk , k = 1, . . . , 4,
was from a uniform distribution such that∑
k mk = N andmk > 2. An initial template with
constant pattern in four periods was simulated from
log
(
μ
(c)
k
)
∼ N (μ, σ 2).
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(2) Sample variability and gene variability: Sample
variability σ 2s was introduced and the cluster
template T (c)j , j = 1, . . . ,N , was generated from
log
(
T (c)j
)
∼ N
(
log
(
μ
(c)
k
)
, σ 2s
)
. Then for each gene
vector i in sample j, gene variability was added and
gene expression values generated as
log(xij) ∼ N
(
log
(
T (c)j
)
, σ 20
)
.
(3) We repeated steps 1 and 2 to generate five clusters.
We used parameter values of μ = 6, σ = 1, σs = 1,
σ0 = 1, and λ = 10.
As in [26], extra variation was introduced to evaluate
robustness of clustering methods against potential ran-
dom errors introduced from experimental procedures,
such as sample acquisition, labeling hybridization and
scanning. To each element of the log-transformed expres-
sion matrix we added a a random error from a normal
distribution with mean zero and standard deviation (SD)
equal to 0, 1 and 2. In addition, the sample size was varied,
using N = 10, and 0. For each of these nine scenarios, 50
datasets were generated.
For each dataset, three scenarios for the available prior
information were used. In (A), we assumed that no prior
information was used. In (B), we assumed priors pairs
were available, where 20% where mis-specified, i.e. 20%
of the gene pairs had members belonging to different
groups. In the last scenario (C), all pairs were assumed
to be correctly specified (the members belonged to the
same group). Prior values were generated from a uniform
U(0.5,1) distribution.
We compared our method with five well-known clus-
tering methods for which a software already exist, namely
hierarchical clustering, k-means clustering, Partitioning
Around Medoids (PAM) [8], Model-based clustering
(Mclust) [9] and tight clustering [11]. For all methods
except ours, the number of clusters were estimated using
the Gap index [27] (our method implicitly searches for
the optimal number of clusters). For our method, clus-
ters were inferred by minimizing the posterior expected
loss based on the MCMC samples as described in the
Methods section. The number of clusters estimated by the
GAP index as well as our method is shown by boxplots
in Additional file 3: Figure S2. The Rand index, defined
as the proportion of concordant gene pairs in two parti-
tions among all possible gene pairs, was used as evaluation
measure. Specifically, we used the adjusted Rand index
[28], which is standardized to have expected value zero
when the partitions are randomly generated and takes
maximum value one if two partitions are perfectly iden-
tical. Unlike the other methods, tight clustering produces
clusters where some genes are not allocated to any clus-
ter. In the calculation of the Rand index, only the allocated
genes are considered.
The results are shown in Figure 1. We see that when
all pairs are correctly specified (scenario C), our method
(MCIP) was at least as good as all other methods, and
superior to the other methods for the smallest sample size
(N= 10).When 20% of the priors were mis-specified (sce-
nario B), the performance was better than our method
without using priors (scenario A), as well as hierarchical
clustering, which was overall the second best method. We
note that Mclust had a very variable performance, and
that tight clustering was performing very poorly for large
sample sizes. In order to further investigate the effect of
mis-specifications of the priors on model performance,
we calculated the adjusted Rand index for increasing pro-
portion of mis-specifications. Additional file 4: Figure S1
shows that about 40% mis-specifications were allowed, in
the sense that this corresponded to the use of no prior
information. We also note that there was a correspon-
dence between number of estimated clusters (Additional
file 3: Figure S2) and performance (Figure 1). Especially for
small sample sizes (N= 10), the number of clusters found
by maximizing the GAP index, as well as with our method
without the use of priors, quite often yielded many more
clusters than the true number of clusters (equal to five).
This bias was much less evident for our method with the
use of priors (MCIP-B and MCIP-C). Additional file 5:
Figure S3 shows the performance after fixing the num-
ber of clusters to the true number of clusters (five) for all
methods except our method, which inherently finds the
number of clusters. The figure shows that poor perfor-
mance, especially seen for tight clustering (N= 100 and
N= 1000) and Mclust (N= 100), was not only due to bias
in the estimation of number of clusters, as these methods
also performed poorly after fixing the number of clusters.
Heart failure data
We used the data described in [29], consisting of microar-
ray gene expression measurements from fourteen mice
subjected to aortic banding and five sham operated mice.
Aortic banding leads to increased left ventricular pres-
sure. To compensate for the increased load, gene expres-
sion changes occur resulting in myocardial remodeling,
involving hypertrophy of cardiomyocytes. Ultimately, the
cardiac hypertrophy might lead to development of heart
failure. We based our network analysis on the most dif-
ferentially expressed genes between aortic banding and
sham. To find differentially expressed genes we performed
t-tests between the two groups, using log2 expression
values, before multiple testing correction was performed
using the method of [30]. We used a false discovery rate
(FDR) cut-off of 5%, and among these genes we picked
the 400 with largest fold change (up or down). We looked
up connections between these genes and assigned prior
probabilities for the pairs based on the prior databases
described in the previous section. For each of the three
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Figure 1 Results on simulated data.We have used the simulation scheme proposed by [26] sampling approximately 100 genes per data set.
Sample sizes (N) were varied using N= 10, and 0, as well as an extra variation (SD) added to each element in the expression matrix, using SD= 10,
and 0. hclust= hierarchical clustering, kmeans= k-means clustering, PAM= Prediction Around Medoids, Mclust=model-based clustering,
tight= tight clustering, MCIP-A, is our method (MCMC Clustering using Informative Priors), but with no priors used, MCIP-B is our method using
priors with 20% of the priors mis-specified, and MCIP-C is our method with all prior pairs correctly specified.
prior databases, there were several hundred pairs where
both genes were represented in our input-list. As the use
of so many priors pairs was too computationally demand-
ing for our method, we picked the 50 top scoring pairs
for each of the prior types. We applied our MCMC algo-
rithm using altogether 150000Monte Carlo samples, with
the first 50000 samples used for burn-in (i.e these first
samples were discarded and only used to ascertain a stable
starting point in the MCMC sampling). We applied par-
allel tempering as described in Additional file 1. As we
here hadmore than hundred prior pairs, we approximated
P(g | M) with the Monte Carlo estimator (1) defined
in Additional file 1, using K = 200, as this value gave
stable results within a reasonable computation time. Clus-
ters were inferred by minimizing the posterior expected
loss based on the posterior similarity matrix, which was
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calculated from the collection of each of the 100thMCMC
sample after the burn-in period.
Table 1 summarizes the clusters and Additional file 6:
Figure S4 displays the clusters as (fully connected) net-
works (all nodes in the same cluster are connected)
using Cytoscape [31]. There is one one large module
of mainly up-regulated genes (aorta banding vs sham),
and one smaller module of both up and down-regulated
genes. In order to investigate these modules more thor-
oughly we applied Gene Ontology [32] analysis using the
R/Bioconductor package GOstats [33]. Additional file 7
shows the most significantly altered GO categories in
each of the modules. The top GO term of the larger
module was extracellular region (p = 3e-34, FDR q-
value= 5e-31), and many of the other modules were
related to this term (proteinaceous extra-cellular matrix,
extracellular space, extracellular matrix structural con-
stituent, collagen). In the smaller module many GO terms
were related to carbohydrate metabolism (polysaccha-
ride metabolic process, carbohydrate biosynthetic process).
Figure 2 contains a subset of the larger network, show-
ing prior pairs occurring within the main module. We
also applied our method without the use of priors, as well
as k-means clustering. For the latter, the Gap index was
used to find the number of clusters K. Both these meth-
ods gave one dominant cluster and two smaller clusters.
GO analyses of the main clusters are given in Additional
files 8 and 9.
Melanoma cancer data
Metastatic melanoma is a deadly disease while non-
metastatic melanoma and other cutaneous tumor types
are usually cured with surgical removal of the primary
tumors. To find network of genes differentially expressed
between metastatic and non-metastatic tumors we used
data from [34], which included microarray gene expres-
sions from 47 metastatic and 40 non-metastatic tumor
samples of patients with various cutaneous tumors. As
for the heart failure data, we used the 400 most differen-
tially expressed genes (based on fold change) for which
Benjamini Hochberg FDR<0.05, and found gene pairs
in the PPI, the TF and the sequence similarity database
where both genes were represented in our input list.
We also here approximated P(g | M) with the Monte
Carlo estimator (1) of the Additional file 1, using K =
samples. Again, result clusters were inferred by mini-
mizing the posterior expected loss based on the poste-
rior similarity matrix calculated from each th of 150K
MCMC samples generated after a burn-in period of 50K
samples.
Table 2 summarizes the clusters/modules and
Additional file 10: Figure S5 shows the modules as
(fully connected) networks. Figure 3 shows prior pairs
within each module. The top ten GO categories from
GOstats analysis on each module are shown in Additional
file 11. We note that the top three GO categories of the
largest module were epidermis development (p=6e-32,
FDR q-value=8e-29), cornified envelope (p=2e-18, FDR
q-value=3e-15) and keratinization (p =1e-14, FDR q-
value=3e-15). We also applied our method without the
use of priors and k-means clustering to the melanoma
data. GO analyses of the main clusters are given in
Additional files 12 and 13.
Method evaluation
In order to evaluate our method we made use of literature
reported interactions that occurred in abstracts of articles
labeled with theMedical Subject Headings (MeSH, http://
www.nlm.nih.gov/mesh/) term left ventricular hypertro-
phy for the heart failure clusters (summarized in Table 1
and displayed in Additional file 6: Figure S4) and the
MeSH term melanoma for the melanoma clusters (sum-
marized in Table 2 and displayed in Additional file 10:
Figure S5). We applied gene pairs with p-values smaller
than 5% only, using the method described in [35]. We will
refer to these interactions as "true" interactions. The appli-
cation of our method together with minimization of the
posterior expected loss led to an inferred clustering. By
considering whether the genes of each possible gene pair
occurred in the same group or not in the inferred cluster-
ing, we were able to calculate the sensitivity (proportion
of gene pairs in the literature network also occurring
together in the same group in the inferred clustering),
the specificity (proportion of gene pairs not in the liter-
ature network that were also not in the same clustering
group), the positive predictive value (proportion of genes
occurring in the same group also occurring in the litera-
ture network). From the sensitivities and specificities the
Area Under Curve (AUC) was also calculated. Table 3
shows performance measures for the heart failure and
Table 1 Summarizing the inferred heart failure clusters
Cluster Size Upreg. (%) Edges Priors (%) Top three GO terms
1 315 89.3 98910 0.4 Extracellular region, basement membrane, proteinaceous extracellular matrix
2 85 28.4 7140 0.1 Positive regulation of cell cycle, polysaccharide metabolic process, carbohydrate
biosynthetic process
Size =number of genes in each cluster, Upreg. (%)=percentage of upregulated genes, Edges=number of edges, Priors (%)=percentage of edges that were prior
pairs, and Top three GO terms= the three most significant Gene Ontology terms found by GOstats [33].
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Figure 2 Heart failure result networks. Network comprised of prior pairs within the main module. Red node color means upregulated in aorta
banding vs sham, green color downregulated. Red edges depict known protein-protein interactions, green edges transcription factor bindings, and
blue edges illustrate protein sequence homologies. Text on protein-protein interaction edges denote type of interactions (MI), lowest pmid reuse
(lpr) and number of publications (np), text on transcription factor binding edges denote prediction score, and text on protein homology edges
denote sequence similarity.
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Table 2 Summarizing the inferredmelanoma cancer clusters
Cluster Size Upreg. (%) Edges Priors (%) Top three GO terms
1 130 2.3 16770 1.3 Epidermis development, cornified envelope, keratinization
2 25 4.0 600 0.0 Androgen biosynthetic process, extracellular region, desmosome
3 28 3.6 756 1.7 Forebrain morphogenesis, response to vitamin A, negative regulation of neuron maturation
4 25 0.0 600 1.2 Keratinization, peptide cross-linking, desmosome
5 17 52.9 272 1.8 Testosterone 16-alpha-hydroxylase activity, negative regulation of Rho GTPase activity,
negative regulation of epidermal growth factor-activated receptor activity
6 13 61.5 156 1.9 Alcohol sulfotransferase activity, CDP-diacylglycerol biosynthetic process, embryonic
hindgut morphogenesis
7 13 53.8 156 1.3 Regulation of mesonephros development, negative regulation of cell proliferation involved
in mesonephros development, negative regulation of fibroblast growth factor receptor
signaling pathway involved in ureteric bud formation
8 12 0.0 132 0.0 Glutamate dehydrogenase (NAD+) activity, glutamate dehydrogenase [NAD(P)+] activity,
negative regulation of myelination
9 12 16.7 132 1.5 Serine-type endopeptidase activity, serine hydrolase activity, peptidase activity, acting on
L-amino acid peptides
10 10 50.0 90 0.0 Adherens junction organization,interleukin-1 Type I receptor binding, dihydrotestosterone
17-beta-dehydrogenase activity
11 10 0 90 1.1 N-acylglucosamine 2-epimerase activity, osteoclast proliferation, alkaloid catabolic process
12 10 30.0 90 0.0 Middle ear morphogenesis, vagus nerve morphogenesis, activation of phospholipase
D activity by G-protein coupled receptor protein signaling pathway
13 11 9.1 110 0.9 Scavenger receptor activity, negative regulation of collateral sprouting of intact axon
in response to injury, regulation of cell adhesion
14 11 0.0 110 0.9 Positive regulation of cell development, regulation of cell morphogenesis involved in
differentiation, argininosuccinate synthase activity
15 12 16.7 132 0.0 Pharynx development, cellular response to external biotic stimulus, nucleus
16 9 0.0 72 1.4 Alpha-dystroglycan binding, isopeptide cross-linking via N6-(L-isoglutamyl)-L lysine,
positive regulation of arachidonic acid secretion
17 7 100.0 42 14.3 Vascular transport, interleukin-1 Type II blocking receptor activity, Golgi cis cisterna
18 6 66.7 30 3.3 NLRP1 inammasome complex, 17-alpha,20-alpha-dihydroxypregn-4-en-3-one
dehydrogenase activity, androsterone dehydrogenase (B-specific) activity
Size = number of genes in each cluster, Upreg. (%) = percentage of upregulated genes, Edges =number of edges, Priors (%) = percentage of edges that were
prior pairs, and Top three GO terms = the three most significant Gene Ontology terms found by GOstats [33].
the melanoma data, respectively, using our method both
with and without priors, and compared to the results of
k-means clustering. For k-means clustering the optimal
number of clusters was found using the Gap index.
Discussion
Using simulated data we compared our method to estab-
lished clustering methods as k-means and hierarchical
clustering. When no prior information is provided our
method did not offer any gains over other standard
approaches, except for the N= 10, SD= 0 regime. When
most priors were correctly specified (80% or 100%), our
method was as least as good as the best-performing estab-
lishedmethods for large samples, and superior to the same
methods for small sample sizes.We believe that themajor-
ity of the priors will be correctly specified in most cases.
The reason for this is that there will usually exist so many
prior pairs that one would restrict oneself to only those
with the strongest evidence. Of course, a previously shown
connection might still not be real in the current situation,
e.g. if the connection has been discovered in a different tis-
sue type than the one under study. However, this problem
will be limited if one is analyzing a set of genes differen-
tially expressed between two conditions, as many of these
will be co-expressed, and thus also correlated.
The Gene Ontology analysis of the heart failure net-
work showed that many of the top ranked GO categories
for the larger module were related to the extracellular
matrix. Awareness has emerged regarding the extracellu-
lar matrix changes taking place in myocardial remodeling
[36,37].When investigating Figure 2, we see that the larger
module contains many collagens (type I alpha 1, type III
alpha 1, type IV alpha 1, type V alpha 1, type VI alpha
1, type XII alpha 1, type XIV alpha 1 and type XVI a),
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Figure 3 Melanoma cancer result networks. Prior pairs within the largest module. Red node color means upregulated in metastatic melanoma,
green color downregulated. Red edges illustrate known protein-protein interactions, green edges transcription factor bindings, and blue edges
protein sequence homologies. Text on protein-protein interaction edges denote type of interactions (MI), lowest pmid reuse (lpr) and number of
publications (np), text on transcription factor binding edges denote prediction score, and text on protein homology edges denote sequence
similarity.
which are important structural components of the extra-
cellular matrix. The figure shows that these molecules
were primarily connected by protein sequence homol-
ogy (blue lines). Moreover, other molecules thought to
be parts of the extracellular matrix were identified in
the same module (thrombospondin 3 and 4, fibromod-
ulin, versican, biglycan, fibronectin, elastin). For example,
fibronectin has been demonstrated to play a role in the
organizing of collagen type I [38]. The module also con-
tained enzymes and hormonal factors known to process
Table 3 Comparing performance of our method (MCIP) with andwithout the use of priors to k-means clustering
Heart failure data Melanoma data
Sens. Spec. PPV AUC K Sens. Spec. PPV AUC K
MCIP with priors 0.62 0.68 0.023 0.65 2 0.67 0.6 0.030 0.64 18
MCIP without priors 0.61 0.64 0.020 0.62 3 0.68 0.53 0.024 0.60 20
Kmeans 0.52 0.65 0.019 0.59 3 0.70 0.48 0.021 0.58 10
The performances are obtained by evaluating the result clusters against a literature based reference network comprising pairs of genes co-cited in Pubmed articles
with the Medical Subject Headings (MeSH) left ventricular hypertrophy (for the heart failure data) and melanoma cancer (for the melanoma cancer data). Sens.=
sensitivity, Spec.= specificity, PPV= Positive predictive value, AUC=Area under receiver operator curve, and K =number of clusters, which is automatically found by
our method, and by using the Gap index for k-means clustering.
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the extracellular matrix structural proteins (matrix metal-
lopeptidase 2, transforming growth factor beta 2 and beta
3, latent transforming growth factor beta binding protein
2, lysyl oxidase, TIMP metallopeptidase inhibitor 1). For
instance, matrix metallopeptidase 2 is known to be impor-
tant for the breakdown of collagen type I [39]. Finally,
the extracellular matrix related transcription factor early
growth response 3 was a hub in this module, indicat-
ing a particular importance in this pathological process.
Altered metabolism has been described in remodeled and
failing hearts. E.g. reduced fatty acid oxidation and an
increase in glucose utilization have been reported [40-
42]. The smaller module contained several genes involved
in carbohydrate metabolic processes (6-phosphofructo-
2-kinase, phosphorylase kinase gamma 1, aldolase B
fructose-bisphosphate, fructose bisphosphatase 2). Taken
together, the two modules confirm regulatory and signal-
ing events and structural alterations known to be involved
in myocardial remodeling. We believe that the complete
result network, shown in Additional file 6: Figure S4,
contains many other important, not yet discovered, inter-
actions. However, a detailed investigation of all these
connections is beyond the scope of this paper.
The melanoma network was derived from the data of
Riker et al. [34]. As the present paper represents a reanal-
ysis of the data, the outcome of an analysis with similar
input data should be expected to generate somewhat
similar output data. The main difference in approach is
that while the Riker paper primarily performs a direct
Gene Ontology analysis, the current approach attempts
to combine multiple sources of information prior to per-
forming any functional analysis. In this way, the resul-
tant network modules will represent subnets of relevance
with respect to the combined prior information, thus
presenting local information clusters with higher like-
lihood of coherence in function for each cluster. Riker
et al. observed differentially expressed genes involved
in keratinocyte differentiation and epidermal develop-
ment, including loricrin (LOR), involucrin (IVL), keratin
5 (KRT5) and plakophilin 1 (PKP1), suggesting a loss of
epidermal characteristics, in highlighting the desquama-
tion process. In our largest module (module 1) we found
many genes related to keratinocyte differentiation and
epidermal development (see Additional file 11, Table 1).
When looking at Figure 3, where gene pairs with prior
information within each module were connected, we note
that keratins and kallikreins were connected through a set
of interacting genes that included desmocollin 1 and 3
(DSC1 and DSC3), desmoglein 1 and 3 (DSG1 and DSG3),
desmoplakin (DSP) and corneodesmosin (CDSN). Many
of the genes in this path are related to corneodesmo-
somes (KLK5 and KLK7: kallikrein 5 and 7, DSG1, DSG3,
DSC1, DSC3, DSP, IVL, LOR and keratin 10). Cor-
neodesmosomes are located at the junctional structures
that mediate corneocyte cohesion [43], underlining ker-
atinocyte dedifferentiation. The individual connections
in this path are supported by previous findings; Caubet
et al. [43] showed that KLK5 and KLK7 degrade the
desmosomal proteins DSC1 and DSG1. Smith et al. [44]
showed that when epidermal cells differentiate, DSC1 and
DSG1 are bound by PKP1 and DSP, thereby enhancing
anchorage to keratin intermediate filaments. Interactions
between plakophilins, desmoplakins and keratins have
also been shown by other authors, e.g. [45-47]. Interest-
ingly, the transcription factor RAR-related orphan recep-
tor A (RORA) was downregulated, and placed as a hub
in this module. RORA has recently been indicated as a
breast tumor suppressor [48], as well as having a role in
keratinocyte differentiation [49]. Taken together, Figure 3
suggests that the loss of epidermal characteristics seen in
the metastatic individuals is mediated by a downregula-
tion of the RORA transcription factor.
When comparing the GO analysis of the main clusters
from our method with the use of priors (Additional file 7
and 11) to the GO analysis of the main clusters using our
method without priors (Additional files 8 and 9) and k-
means clustering (Additional files 9 and 13), we note that
many of the same GO categories were showing up. But
the p-values were overall much smaller for our method
with the use of priors, than the other two, indicating that
our method has better sensitivity of finding functionally
related gene groups. We note that the path found in the
melanoma data linking the RORA transcription factor to
the keratins via the kallikreins and the desmosomal pro-
teins, would not have been discovered by our method
without priors or k-means clustering, as none of the these
methods gave clusterings where all these gene subgroups
were contained in one cluster.
Method evaluation using the literature-derived network
showed that adding prior knowledge yielded improved
AUC. The AUC was improved from 0.62 to 0.65 for the
heart failure data and from 0.6 to 0.64 for the melanoma
data. The positive predicted values (PPV) were also
improved (0.02 to 0.023 for the heart failure data and 0.024
to 0.03 for the melanoma data). We note that these values
are very small, which is because there are very few gene
pairs with co-citation (only around one in a hundred of all
possible pairs) compared to the number of gene pairs clus-
tered together (more than half of the pairs for the heart
failure data, for instance). It is important to be aware that
the possibility of improvement is limited by the degree of
overlap between the list of pairs in the prior interaction
databases and list of pairs in the literature reference net-
work. Many of the pairs in the literature databases were
not found in the interaction databases. In fact this was
the case for about 90% for these data. Such interactions
are, when evaluated on the literature network, treated as
false positives, but might of course be true positives. Of
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the 90% of the pairs in the literature network that were
not in the prior databases, the evidence for grouping the
genes together was based solely on the correlation in the
microarray data. Another limitation of the literature net-
work is that it itself might contain false positives. Genes
that are mentioned in the same PubMed abstract are not
necessarily connected.
We have here focused on finding groups of connected
genes, and not on discovering direct interactions. Direct
interactions are often inferred using Bayesian networks
(BN). As mentioned in the Background section, the BN
formalism allows for incorporation of prior knowledge,
and BN methods for genomic data has indeed been pro-
posed. However, constructing large-scale networks using
BN methodology is very difficult as the number of pos-
sible configurations is about exponential in the number
of genes. Formally this has been shown to be an NP-
Complete problem. By instead focusing on groups, we
heavily reduce the number of possible configurations.
Thus, our method can handle many more genes than BN
methods. This is relevant, as microarray data may involve
several hundred regulated genes. One way of using our
method is to apply it as an initial step prior to a BN
analysis; If the number of genes is too large to apply BN
methodology to the full set, our method can be used to
first find smaller-sized, independent sets of genes, fol-
lowed by separate BN analysis on each of the subsets. The
result of such an analysis will be similar to the networks
shown in Figures 2 and 3, where prior pairs within each
cluster are shown.We believe that the connections shown
in Figures 2 and 3 are reliable and robust, as they dis-
play connections between genes that are co-regulated and
that have a previously shown connection. Using BN on
each cluster could lead to an improvement, as novel inter-
actions can be detected based on strong correlations in
the data, and is one possibility for future methodological
development.
Along with the development of the primarily data-
driven methods, various methods focusing more on the
prior information have been proposed, e.g. [5,50,51]. In
these approaches, the authors made use of the observed
changes in the experimental data, e.g. the most differ-
entially regulated genes, while the interactions among
these genes were derived from prior information only.
For example, Huang et al. [5] applied the so-called Prize-
collecting Steiner tree to select nodes and interactions. As
we speak, the prior knowledge about molecular interac-
tions is rapidly increasing. For instance, the data generated
by the large-scale consortium project Encode [52] repre-
sent huge possibilities for extending the source of prior
knowledge about transcriptional regulation. Obviously,
methods enabling the use of prior knowledge when con-
structing genetic networks will increase their relevance in
line with this development.
Conclusions
We have presented a novel method for finding modules of
interactingmolecules, representing biological pathways or
processes, based on microarrays or other transcriptomic
data. Themethod is a clustering approach, which is a com-
monly used technique for analyzing transcriptomic data.
Unlike previous approaches using Bayesian statistics to
infer clusters, e.g. [9,10], we used informative (as opposed
to non-informative) priors. The prior information was
assumed to be in form of pairs of connected genes, along
with a connection score, as this enabled us to capture
a lot of relevant prior information, like protein-protein
interactions, transcription factor binding information and
protein sequence similarity measurements. Using simu-
lated data our method showed improved ability of iden-
tifying correct groups compared to traditional clustering,
especially for small sample sizes, and for situations where
most priors were correctly specified. When applying the
method to real-world microarray data in heart failure
and melanoma cancer we found clusters overlapping with
known pathogenic processes, but where subnetworks of
prior pairs within each cluster pointed to new connections
extending beyond the classical disease pathways.
Availability
The method is implemented in C++ and R and is avail-
able from: http://folk.uio.no/trondr/gene_corr, as well
as a tool in the Galaxy [53] based Genomic Hyper-
Browser [54], see http://hyperbrowser.uio.no/dev2 under
assorted tools→MCMC gene corr. The data sets sup-
porting the results of this article are available from the
Gene Expression Omnibus repository: http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE36074 (heart fail-
ure data) and http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE7553 (melanoma cancer data).
Additional files
Additional file 1: Calculations and parallel tempering description.
Calculations of expressions used in the MCMC algorithm and description of
the use of parallel tempering.
Additional file 2: Monte Carlo estimation of prior. Evaluation of the
precision of the Monte Carlo estimates of the prior compared to the exact
calculation.
Additional file 3: Figure S2. Number of estimated clusters. GAP index is
used for all methods except ours, which inherently finds the number of
clusters. hclust= hierarchical clustering, kmeans= k-means clustering,
PAM= Prediction Around Medoids, Mclust=model-based clustering,
tight= tight clustering, MCIP-A, is our method (MCMC Clustering using
Informative Priors), but with no priors used, MCIP-B is our method using
priors with 20% of the priors mis-specified, and MCIP-C is our method with
all prior pairs correctly specified.
Additional file 4: Figure S1. Investigation of the effect of mis-specified
priors on model performance. The figure shows boxplots of adjusted Rand
index values for 50 simulated datasets using the simulation set-up
described in the Results section, using extra variation SD of 0, 1 and 2, and
number of individuals N of 10, and 0.
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Additional file 5: Figure S3. Evaluation of performance in terms of
adjusted Rand index following the simulation scheme of [26]. The
simulation setup is identical to the one generating Figure 1, except that for
this figure the number of clusters where fixed to the true number of
clusters (five). hclust= hierarchical clustering, kmeans= k-means
clustering, PAM= Prediction Around Medoids, Mclust=model-based
clustering, tight= tight clustering, MCIP-A, is our method (MCMC
Clustering using Informative Priors), but with no priors used, MCIP-B is our
method using priors with 20% of the priors mis-specified, and MCIP-C is
our method with all prior pairs correctly specified.
Additional file 6: Figure S4. The results of applying our method to the
most differentially expressed genes between aorta banding and sham in
the microarray heart failure data. Red node color means upregulated in
aorta banding vs sham, green color downregulated.
Additional file 7: GO results MCIP with priors, heart failure data.
Results of Gene ontology analysis using GOstats [33] of heart failure
clusters found using our method with priors.
Additional file 8: GO results MCIP without priors, main cluster, heart
failure data. Results of Gene ontology analysis of main heart failure cluster
found using our method without priors.
Additional file 9: GO results Kmeans clustering, main cluster, heart
failure data. Results of Gene ontology analysis of main heart failure cluster
found using Kmeans clustering.
Additional file 10: Figure S5. The results of applying our method to the
most differentially expressed genes between metastatic and
non-metastatic melanoma cancer patients. Red node color means
upregulated in metastatic melanoma, green color downregulated.
Additional file 11: GO results MCIP with priors, melanoma data.
Results of Gene ontology analysis of melanoma clusters found using our
method with priors.
Additional file 12: GO results MCIP without priors, main cluster,
melanoma cancer data. Results of Gene ontology analysis of main
melanoma cluster found using our method without priors.
Additional file 13: GO results Kmeans clustering, main cluster,
melanoma cancer data. Results of Gene ontology analysis of main
melanoma cluster found using Kmeans clustering.
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